Xtrackers
XDG3.L
IE00036F4K40
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
25.58
Weighted Fwd P/E
17.98
Avg P/FCF
27.71
Avg FCF Yield
3.44%
Avg EV / EBITDA
25.34
Avg EV / Revenue
6.65
Avg Price-to-Book (P/B)
35.27
Avg Price-to-Sales (P/S)
6.39
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-29.71%
Avg Debt-to-Equity (D/E)
110.89%
<50% (22.79%) 50-150% (49.92%) >150% (20.82%) Unreported (6.47%)

Profitability Analysis

130 Holdings Count
Profitable 99.03%
Profitable 99.03%
109 Holdings Count (83.85%)
Unprofitable 0.97%
21 Holdings Count (16.15%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

Moderate Concentration
Top 5
24.3%
Top 10
45.6%
Top 25
79.7%
50% Threshold
Top 12
The top 10 positions account for 45.6% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

17 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (19.1%+)
High (49.7%+)
Top (68.8%+)

Country Breakdown

Max: 76.43%
US US US
76.43%
GB GB GB
5.66%
DK DK DK
4.12%
JP JP JP
2.45%
FR FR FR
2.35%
NL NL NL
2.24%
IE IE IE
2.21%
AU AU AU
1.06%
CH CH CH
1.04%
CN CN CN
0.84%
SE SE SE
0.69%
TW TW TW
0.40%
IT IT IT
0.23%
MX MX MX
0.08%
DE DE DE
0.04%
HK HK HK
0.03%
ES ES ES
0.03%

Sector Distribution

5 Sector
Healthcare
98.03%
Consumer Defensive
1.36%
Industrials
0.46%
Unknown
0.08%
Consumer Cyclical
0.06%

Industry Distribution

12 Industries
Drug Manufacturers - General
43.75%
Medical Devices
17.21%
Biotechnology
15.92%
Diagnostics & Research
14.03%
Drug Manufacturers - Specialty & Generic
3.65%
Medical Instruments & Supplies
3.32%
Other
2.12%

Market Cap Distribution

130 Holdings Count
Mega Cap (> 200B)
(7) 31.81%
Large Cap (10B - 200B)
(46) 60.63%
Mid Cap (2B - 10B)
(40) 6.34%
Small / Micro Cap (< 2B)
(22) 1.14%
Unclassified
(15) 0.08%
ende